BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Amidon S, Brown JE, Dave VS. Colon-targeted oral drug delivery systems: design trends and approaches. AAPS PharmSciTech. 2015;16:731-741. [PMID: 26070545 DOI: 10.1208/s12249-015-0350-9] [Cited by in Crossref: 161] [Cited by in F6Publishing: 128] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Luo SX, Zhang RX, Huang Q, Xu LS, Wang ZZ. Macromolecular drug conjugates II: chemical and enzymatic hydrolysis kinetics of the secondary 5-fluorouracil-1-acetic acid/β-cyclodextrin conjugate. J Incl Phenom Macrocycl Chem 2016;86:167-71. [DOI: 10.1007/s10847-016-0639-7] [Reference Citation Analysis]
2 Shahdadi Sardou H, Akhgari A, Mohammadpour AH, Beheshti Namdar A, Kamali H, Jafarian AH, Afrasiabi Garekani H, Sadeghi F. Optimization study of combined enteric and time-dependent polymethacrylates as a coating for colon targeted delivery of 5-ASA pellets in rats with ulcerative colitis. Eur J Pharm Sci 2021;168:106072. [PMID: 34774715 DOI: 10.1016/j.ejps.2021.106072] [Reference Citation Analysis]
3 Steiger C, Phan NV, Sun H, Huang HW, Hess K, Lopes A, Korzenik J, Langer R, Traverso G. Controlled Delivery of Bile Acids to the Colon. Clin Transl Gastroenterol 2020;11:e00229. [PMID: 33512801 DOI: 10.14309/ctg.0000000000000229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Md S, Abdullah S, Alhakamy NA, Alharbi WS, Ahmad J, Shaik RA, Ansari MJ, Ibrahim IM, Ali J. Development, Optimization, and In Vitro Evaluation of Novel Oral Long-Acting Resveratrol Nanocomposite In-Situ Gelling Film in the Treatment of Colorectal Cancer. Gels 2021;7:276. [PMID: 34940336 DOI: 10.3390/gels7040276] [Reference Citation Analysis]
5 Kim W, Yang Y, Kim D, Jeong S, Yoo JW, Yoon JH, Jung Y. Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes. Drug Des Devel Ther 2017;11:419-29. [PMID: 28243064 DOI: 10.2147/DDDT.S129922] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
6 Arya A, Majumdar DK, Pathak DP, Sharma AK, Ray AR. Design and evaluation of acrylate polymeric carriers for fabrication of pH-sensitive microparticles. Drug Development and Industrial Pharmacy 2017;43:305-18. [DOI: 10.1080/03639045.2016.1239629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 García-couce J, Bada-rivero N, López Hernández OD, Nogueira A, Caracciolo PC, Abraham GA, Ramón Hernández JA, Peniche C. Dexamethasone-Loaded Chitosan Beads Coated with a pH-Dependent Interpolymer Complex for Colon-Specific Drug Delivery. International Journal of Polymer Science 2019;2019:1-9. [DOI: 10.1155/2019/4204375] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Liu D, Yan H, Kong Y, You Y, Li Y, Wang L, Tong Y, Wang J. Preparation of Colon-Targeted Acetylharpagide Tablets and its Release Properties in vivo and in vitro. Front Pharmacol 2018;9:832. [PMID: 30154716 DOI: 10.3389/fphar.2018.00832] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sharif H, Hoad CL, Abrehart N, Gowland PA, Spiller RC, Kirkham S, Loganathan S, Papadopoulos M, Benninga MA, Devadason D, Marciani L. Colonic Volume Changes in Paediatric Constipation Compared to Normal Values Measured Using MRI. Diagnostics (Basel) 2021;11:974. [PMID: 34071217 DOI: 10.3390/diagnostics11060974] [Reference Citation Analysis]
10 Murray K, Hoad CL, Mudie DM, Wright J, Heissam K, Abrehart N, Pritchard SE, Al Atwah S, Gowland PA, Garnett MC, Amidon GE, Spiller RC, Amidon GL, Marciani L. Magnetic Resonance Imaging Quantification of Fasted State Colonic Liquid Pockets in Healthy Humans. Mol Pharmaceutics 2017;14:2629-38. [DOI: 10.1021/acs.molpharmaceut.7b00095] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
11 Kamakura R, Kovalainen M, Riikonen J, Nissinen T, Shere Raza G, Walkowiak J, Lehto V, Herzig K. Inorganic mesoporous particles for controlled α-linolenic acid delivery to stimulate GLP-1 secretion in vitro. European Journal of Pharmaceutics and Biopharmaceutics 2019;144:132-8. [DOI: 10.1016/j.ejpb.2019.09.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Kaffash E, Abbaspour M, Afrasiabi Garekani H, Jahanian Z, Saremnejad F, Akhgari A. The Effect of Thermal-Treating on Drug Release from Sustained Release Alginate-Eudragit RS Matrices. Adv Pharm Bull 2021;11:318-26. [PMID: 33880354 DOI: 10.34172/apb.2021.027] [Reference Citation Analysis]
13 Ma Z, Ma R, Xiao X, Zhang Y, Zhang X, Hu N, Gao J, Zheng Y, Dong D, Sun Z. Azo polymeric micelles designed for colon-targeted dimethyl fumarate delivery for colon cancer therapy. Acta Biomaterialia 2016;44:323-31. [DOI: 10.1016/j.actbio.2016.08.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
14 Hitchings R, Kelly L. Predicting and Understanding the Human Microbiome's Impact on Pharmacology. Trends Pharmacol Sci 2019;40:495-505. [PMID: 31171383 DOI: 10.1016/j.tips.2019.04.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
15 Shahdadi Sardou H, Akhgari A, Afrasiabi Garekani H, Sadeghi F. Screening of different polysaccharides in a composite film based on Eudragit RS for subsequent use as a coating for delivery of 5-ASA to colon. International Journal of Pharmaceutics 2019;568:118527. [DOI: 10.1016/j.ijpharm.2019.118527] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
16 Hosseini S, Epple M. Suppositories with bioactive calcium phosphate nanoparticles for intestinal transfection and gene silencing. Nano Select 2021;2:561-72. [DOI: 10.1002/nano.202000150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Parhi R, Jena GK. An updated review on application of 3D printing in fabricating pharmaceutical dosage forms. Drug Deliv Transl Res 2021. [PMID: 34613595 DOI: 10.1007/s13346-021-01074-6] [Reference Citation Analysis]
18 Hens B, Corsetti M, Spiller R, Marciani L, Vanuytsel T, Tack J, Talattof A, Amidon GL, Koziolek M, Weitschies W, Wilson CG, Bennink RJ, Brouwers J, Augustijns P. Exploring gastrointestinal variables affecting drug and formulation behavior: Methodologies, challenges and opportunities. International Journal of Pharmaceutics 2017;519:79-97. [DOI: 10.1016/j.ijpharm.2016.11.063] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 12.2] [Reference Citation Analysis]
19 Shaikh M, Desai N, Momin M, Bhatt LK. Formulation development and in-vitro/ex-vivo evaluation for a polysaccharide-based colon targeted matrix tablet. Curr Drug Deliv 2021. [PMID: 34238183 DOI: 10.2174/1567201818666210708121739] [Reference Citation Analysis]
20 Stamatopoulos K, Batchelor HK, Simmons MJ. Dissolution profile of theophylline modified release tablets, using a biorelevant Dynamic Colon Model (DCM). European Journal of Pharmaceutics and Biopharmaceutics 2016;108:9-17. [DOI: 10.1016/j.ejpb.2016.08.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
21 Sun L, Cai J, Gonzalez FJ. The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer. Nat Rev Gastroenterol Hepatol 2021;18:335-47. [PMID: 33568795 DOI: 10.1038/s41575-020-00404-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
22 Lu L, Chen G, Qiu Y, Li M, Liu D, Hu D, Gu X, Xiao Z. Nanoparticle-based oral delivery systems for colon targeting: principles and design strategies. Science Bulletin 2016;61:670-81. [DOI: 10.1007/s11434-016-1056-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
23 Khvostov MV, Borisov SA, Tolstikova TG, Dushkin AV, Tsyrenova BD, Chistyachenko YS, Polyakov NE, Dultseva GG, Onischuk AA, An'kov SV. Supramolecular Complex of Ibuprofen with Larch Polysaccharide Arabinogalactan: Studies on Bioavailability and Pharmacokinetics. Eur J Drug Metab Pharmacokinet 2017;42:431-40. [PMID: 27351190 DOI: 10.1007/s13318-016-0357-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
24 Byrne J, Huang HW, McRae JC, Babaee S, Soltani A, Becker SL, Traverso G. Devices for drug delivery in the gastrointestinal tract: A review of systems physically interacting with the mucosa for enhanced delivery. Adv Drug Deliv Rev 2021;177:113926. [PMID: 34403749 DOI: 10.1016/j.addr.2021.113926] [Reference Citation Analysis]
25 Ojha SC, Phanchana M, Harnvoravongchai P, Chankhamhaengdecha S, Singhakaew S, Ounjai P, Janvilisri T. Teicoplanin Suppresses Vegetative Clostridioides difficile and Spore Outgrowth. Antibiotics (Basel) 2021;10:984. [PMID: 34439034 DOI: 10.3390/antibiotics10080984] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Feng K, Wei Y, Hu T, Linhardt RJ, Zong M, Wu H. Colon-targeted delivery systems for nutraceuticals: A review of current vehicles, evaluation methods and future prospects. Trends in Food Science & Technology 2020;102:203-22. [DOI: 10.1016/j.tifs.2020.05.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
27 Barros PD, Dias IFT, Zanin GD, Bunhak ÉJ. Development and evaluation of dapsone tablets coated for specific colon release. Drug Dev Ind Pharm 2020;46:246-52. [PMID: 31951762 DOI: 10.1080/03639045.2020.1716375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 De Anda-flores Y, Carvajal-millan E, Campa-mada A, Lizardi-mendoza J, Rascon-chu A, Tanori-cordova J, Martínez-lópez AL. Polysaccharide-Based Nanoparticles for Colon-Targeted Drug Delivery Systems. Polysaccharides 2021;2:626-47. [DOI: 10.3390/polysaccharides2030038] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Gadalla HH, Mohammed FA, El-Sayed AM, Soliman GM. Colon-targeting of progesterone using hybrid polymeric microspheres improves its bioavailability and in vivo biological efficacy. Int J Pharm 2020;577:119070. [PMID: 31981708 DOI: 10.1016/j.ijpharm.2020.119070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Curcio C, Greco AS, Rizzo S, Saitta L, Musumeci T, Ruozi B, Pignatello R. Development, Optimization and Characterization of Eudraguard®-based Microparticles for Colon Delivery. Pharmaceuticals (Basel) 2020;13:E131. [PMID: 32599861 DOI: 10.3390/ph13060131] [Reference Citation Analysis]
31 Deshmukh S, Paradkar A, Abrahmsén-Alami S, Govender R, Viridén A, Winge F, Matic H, Booth J, Kelly A. Injection moulded controlled release amorphous solid dispersions: Synchronized drug and polymer release for robust performance. Int J Pharm 2020;575:118908. [PMID: 31809859 DOI: 10.1016/j.ijpharm.2019.118908] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Kaur V, Goyal AK, Ghosh G, Chandra Si S, Rath G. Development and characterization of pellets for targeted delivery of 5-fluorouracil and phytic acid for treatment of colon cancer in Wistar rat. Heliyon 2020;6:e03125. [PMID: 32042938 DOI: 10.1016/j.heliyon.2019.e03125] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
33 Arévalo-pérez R, Maderuelo C, Lanao JM. Recent advances in colon drug delivery systems. Journal of Controlled Release 2020;327:703-24. [DOI: 10.1016/j.jconrel.2020.09.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
34 Song L, Liang L, Shi X, Chen H, Zhao S, Chen W, Zhou R, Zhao W. Optimizing pH-sensitive and time-dependent polymer formula of colonic pH-responsive pellets to achieve precise drug release. Asian J Pharm Sci 2019;14:413-22. [PMID: 32104470 DOI: 10.1016/j.ajps.2018.05.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
35 Abdullah S, El Hadad S, Aldahlawi A. The development of a novel oral 5-Fluorouracil in-situ gelling nanosuspension to potentiate the anticancer activity against colorectal cancer cells. Int J Pharm 2021;:121406. [PMID: 34968681 DOI: 10.1016/j.ijpharm.2021.121406] [Reference Citation Analysis]
36 Markovic M, Ben-shabat S, Nagendra Manda J, Abramov-harpaz K, Regev C, Miller Y, Aponick A, Zimmermann EM, Dahan A. PLA2-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy. Pharmaceutics 2022;14:675. [DOI: 10.3390/pharmaceutics14030675] [Reference Citation Analysis]
37 Florian PE, Icriverzi M, Ninciuleanu CM, Alexandrescu E, Trica B, Preda S, Ianchis R, Roseanu A. Salecan-Clay Based Polymer Nanocomposites for Chemotherapeutic Drug Delivery Systems; Characterization and In Vitro Biocompatibility Studies. Materials (Basel) 2020;13:E5389. [PMID: 33260907 DOI: 10.3390/ma13235389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Hong H, Jeong HS, Roh K, Kang I. Preparation of Mesalazine-Clay Composite Encapsulated Alginate (MCA) Bead for Targeted Drug Delivery: Effect of Composite Content and CaCl2 Concentration. Macromol Res 2018;26:1019-25. [DOI: 10.1007/s13233-019-7033-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
39 Khodarahmi M, Abbasi H, Kouchak M, Mahdavinia M, Handali S, Rahbar N. Nanoencapsulation of aptamer-functionalized 5-Fluorouracil liposomes using alginate/chitosan complex as a novel targeting strategy for colon-specific drug delivery. Journal of Drug Delivery Science and Technology 2022;71:103299. [DOI: 10.1016/j.jddst.2022.103299] [Reference Citation Analysis]
40 Incledon B, Incledon C, Gomeni R, Uchida CL, Morris A, Perry K, Kapuscinski J. Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed-Release and Extended-Release Methylphenidate: In Vivo, In Vitro, and Modeling Evaluations. Clin Pharmacol Drug Dev 2022. [PMID: 35316579 DOI: 10.1002/cpdd.1089] [Reference Citation Analysis]
41 Mamidi N, González-Ortiz A, Romo IL, Barrera EV. Development of Functionalized Carbon Nano-Onions Reinforced Zein Protein Hydrogel Interfaces for Controlled Drug Release. Pharmaceutics 2019;11:E621. [PMID: 31757093 DOI: 10.3390/pharmaceutics11120621] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 6.3] [Reference Citation Analysis]
42 Sinha P, Udhumansha U, Rathnam G, Ganesh M, Jang HT. Capecitabine encapsulated chitosan succinate-sodium alginate macromolecular complex beads for colon cancer targeted delivery: in vitro evaluation. Int J Biol Macromol 2018;117:840-50. [PMID: 29807085 DOI: 10.1016/j.ijbiomac.2018.05.181] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
43 Markovic M, Dahan A, Keinan S, Kurnikov I, Aponick A, Zimmermann EM, Ben-Shabat S. Phospholipid-Based Prodrugs for Colon-Targeted Drug Delivery: Experimental Study and In-Silico Simulations. Pharmaceutics 2019;11:E186. [PMID: 30995772 DOI: 10.3390/pharmaceutics11040186] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
44 Iurciuc-Tincu CE, Atanase LI, Ochiuz L, Jérôme C, Sol V, Martin P, Popa M. Curcumin-loaded polysaccharides-based complex particles obtained by polyelectrolyte complexation and ionic gelation. I-Particles obtaining and characterization. Int J Biol Macromol 2020;147:629-42. [PMID: 31904456 DOI: 10.1016/j.ijbiomac.2019.12.247] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
45 Zu M, Ma Y, Cannup B, Xie D, Jung Y, Zhang J, Yang C, Gao F, Merlin D, Xiao B. Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases. Adv Drug Deliv Rev 2021;:113887. [PMID: 34314785 DOI: 10.1016/j.addr.2021.113887] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Longet S, Lundahl MLE, Lavelle EC. Targeted Strategies for Mucosal Vaccination. Bioconjugate Chem 2018;29:613-23. [DOI: 10.1021/acs.bioconjchem.7b00738] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
47 Ispas-szabo P, De Koninck P, Calinescu C, Mateescu MA. Carboxymethyl Starch Excipients for Drug Chronodelivery. AAPS PharmSciTech 2017;18:1673-82. [DOI: 10.1208/s12249-016-0634-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
48 Joseph SK, Sabitha M, Nair SC. Stimuli-Responsive Polymeric Nanosystem for Colon Specific Drug Delivery. Adv Pharm Bull 2020;10:1-12. [PMID: 32002356 DOI: 10.15171/apb.2020.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
49 McGaraughty S, Davis-Taber RA, Zhu CZ, Cole TB, Nikkel AL, Chhaya M, Doyle KJ, Olson LM, Preston GM, Grinnell CM, Salte KM, Giamis AM, Luo Y, Sun V, Goodearl AD, Gopalakrishnan M, Lacy SE. Targeting Anti-TGF-β Therapy to Fibrotic Kidneys with a Dual Specificity Antibody Approach. J Am Soc Nephrol 2017;28:3616-26. [PMID: 28827403 DOI: 10.1681/ASN.2017010013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
50 Othman MH, Zayed GM, Ali UF, Abdellatif AAH. Colon-specific tablets containing 5-fluorouracil microsponges for colon cancer targeting. Drug Development and Industrial Pharmacy 2020;46:2081-8. [DOI: 10.1080/03639045.2020.1844730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Pabari RM, Mattu C, Partheeban S, Almarhoon A, Boffito M, Ciardelli G, Ramtoola Z. Novel polyurethane-based nanoparticles of infliximab to reduce inflammation in an in-vitro intestinal epithelial barrier model. Int J Pharm 2019;565:533-42. [PMID: 31085256 DOI: 10.1016/j.ijpharm.2019.05.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
52 Bhutani U, Basu T, Majumdar S. Oral Drug Delivery: Conventional to Long Acting New-Age Designs. Eur J Pharm Biopharm 2021;162:23-42. [PMID: 33631319 DOI: 10.1016/j.ejpb.2021.02.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Spiridonov VV, Panova IG, Sybachin AV, Kuznetsov VV, Afanasov MI, Alekhina YA, Melik-nubarov NS, Yaroslavov AA. Magneto-Sensitive Multiliposomal Containers for Immobilization and Controlled Delivery of Bioactive Substances. Polym Sci Ser A 2019;61:296-307. [DOI: 10.1134/s0965545x19030167] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Kelly SA, Rodgers AM, O’brien SC, Donnelly RF, Gilmore BF. Gut Check Time: Antibiotic Delivery Strategies to Reduce Antimicrobial Resistance. Trends in Biotechnology 2020;38:447-62. [DOI: 10.1016/j.tibtech.2019.10.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
55 Samprasit W, Akkaramongkolporn P, Jaewjira S, Opanasopit P. Design of alpha mangostin-loaded chitosan/alginate controlled-release nanoparticles using genipin as crosslinker. Journal of Drug Delivery Science and Technology 2018;46:312-21. [DOI: 10.1016/j.jddst.2018.05.029] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
56 Schütt M, Stamatopoulos K, Batchelor HK, Simmons MJH, Alexiadis A. Modelling and Simulation of the Drug Release from a Solid Dosage Form in the Human Ascending Colon: The Influence of Different Motility Patterns and Fluid Viscosities. Pharmaceutics 2021;13:859. [PMID: 34200574 DOI: 10.3390/pharmaceutics13060859] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Bear JC, Patrick PS, Casson A, Southern P, Lin FY, Powell MJ, Pankhurst QA, Kalber T, Lythgoe M, Parkin IP, Mayes AG. Magnetic hyperthermia controlled drug release in the GI tract: solving the problem of detection. Sci Rep 2016;6:34271. [PMID: 27671546 DOI: 10.1038/srep34271] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
58 Li P, Rios Coronado PE, Longstaff XRR, Tarashansky AJ, Wang B. Nanomedicine Approaches Against Parasitic Worm Infections. Adv Healthc Mater 2018;7:e1701494. [PMID: 29602254 DOI: 10.1002/adhm.201701494] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
59 Wang W, Yan X, Li Q, Chen Z, Wang Z, Hu H. Adapted nano-carriers for gastrointestinal defense components: surface strategies and challenges. Nanomedicine: Nanotechnology, Biology and Medicine 2020;29:102277. [DOI: 10.1016/j.nano.2020.102277] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
60 Sahu KK, Kaurav M, Pandey RS. Chylomicron mimicking solid lipid nanoemulsions encapsulated enteric minicapsules targeted to colon for immunization against hepatitis B. Int Immunopharmacol 2019;66:317-29. [PMID: 30503974 DOI: 10.1016/j.intimp.2018.11.041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
61 Deshmukh R. Bridging the Gap of Drug Delivery in Colon Cancer: The Role of Chitosan and Pectin Based Nanocarriers System. Curr Drug Deliv 2020;17:911-24. [PMID: 32679018 DOI: 10.2174/1567201817666200717090623] [Reference Citation Analysis]
62 Ansari M, Sadarani B, Majumdar A. Colon targeted beads loaded with pterostilbene: Formulation, optimization, characterization and in vivo evaluation. Saudi Pharm J 2019;27:71-81. [PMID: 30662309 DOI: 10.1016/j.jsps.2018.07.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
63 Yang W, Bhattachar SN, Patel PJ, Landis M, Patel D, Reid DL, Duvnjak Romic M. Modulating target engagement of small molecules via drug delivery: approaches and applications in drug discovery and development. Drug Discov Today 2021;26:713-23. [PMID: 33333320 DOI: 10.1016/j.drudis.2020.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Patel A, Patel A, Patel R, Dharamsi A. Application of Failure Mode Effect Analysis in Wurster-Based Pelletization Technology: a Technical Note. AAPS PharmSciTech 2019;20. [DOI: 10.1208/s12249-019-1516-7] [Reference Citation Analysis]
65 Kotla NG, Singh R, Baby BV, Rasala S, Rasool J, Hynes SO, Martin D, Egan LJ, Vemula PK, Jala VR, Rochev Y, Pandit A. Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease. Biomaterials 2022;281:121364. [DOI: 10.1016/j.biomaterials.2022.121364] [Reference Citation Analysis]
66 Awad A, Madla CM, McCoubrey LE, Ferraro F, Gavins FKH, Buanz A, Gaisford S, Orlu M, Siepmann F, Siepmann J, Basit AW. Clinical translation of advanced colonic drug delivery technologies. Adv Drug Deliv Rev 2021;181:114076. [PMID: 34890739 DOI: 10.1016/j.addr.2021.114076] [Reference Citation Analysis]
67 Chu HM, Zhang RX, Huang Q, Bai CC, Wang ZZ. Chemical conjugation with cyclodextrins as a versatile tool for drug delivery. J Incl Phenom Macrocycl Chem 2017;89:29-38. [DOI: 10.1007/s10847-017-0743-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
68 Hazra A, Sanyal D, De A, Chatterjee S, Chattopadhyay K, Samanta A. Development and in vitro characterization of capecitabine loaded biopolymeric vehicle for the treatment of colon cancer. J of Applied Polymer Sci. [DOI: 10.1002/app.52374] [Reference Citation Analysis]
69 Teruel AH, Gonzalez-Alvarez I, Bermejo M, Merino V, Marcos MD, Sancenon F, Gonzalez-Alvarez M, Martinez-Mañez R. New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy. Int J Mol Sci 2020;21:E6502. [PMID: 32899548 DOI: 10.3390/ijms21186502] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
70 Das S. Pectin based multi-particulate carriers for colon-specific delivery of therapeutic agents. Int J Pharm 2021;605:120814. [PMID: 34147609 DOI: 10.1016/j.ijpharm.2021.120814] [Reference Citation Analysis]
71 Sarangi MK, Rao MEB, Parcha V. Smart polymers for colon targeted drug delivery systems: a review. International Journal of Polymeric Materials and Polymeric Biomaterials 2021;70:1130-66. [DOI: 10.1080/00914037.2020.1785455] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
72 Regmi S, Pathak S, Nepal MR, Shrestha P, Park J, Kim JO, Yong CS, Choi D, Chang J, Jeong TC, Orive G, Yook S, Jeong J. Inflammation-triggered local drug release ameliorates colitis by inhibiting dendritic cell migration and Th1/Th17 differentiation. Journal of Controlled Release 2019;316:138-49. [DOI: 10.1016/j.jconrel.2019.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
73 Balogh A, Farkas B, Domokos A, Farkas A, Démuth B, Borbás E, Nagy B, Marosi G, Nagy ZK. Controlled-release solid dispersions of Eudragit® FS 100 and poorly soluble spironolactone prepared by electrospinning and melt extrusion. European Polymer Journal 2017;95:406-17. [DOI: 10.1016/j.eurpolymj.2017.08.032] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 6.4] [Reference Citation Analysis]
74 Liu S, Fang Z, Ng K. Recent development in fabrication and evaluation of phenolic-dietary fiber composites for potential treatment of colonic diseases. Crit Rev Food Sci Nutr 2022;:1-25. [PMID: 35225102 DOI: 10.1080/10408398.2022.2043236] [Reference Citation Analysis]
75 Rashid Z, Ranjha NM, Rashid F, Razzaq R. Pharmacokinetic evaluation of novel pH-sensitive poly(2-methoxyethyl methacrylate-co-itaconic acid) microgels in rabbits. Adv Polym Technol 2018;37:3813-7. [DOI: 10.1002/adv.22164] [Reference Citation Analysis]
76 Wahab S, Alshahrani MY, Ahmad MF, Abbas H. Current trends and future perspectives of nanomedicine for the management of colon cancer. Eur J Pharmacol 2021;910:174464. [PMID: 34474029 DOI: 10.1016/j.ejphar.2021.174464] [Reference Citation Analysis]
77 Federica C, Alice M, Saliha M, Marco U, Anastasia F, Alessandra M, Lucia Z, Christel N, Florence S, Juergen S, Andrea G. Injection Molded Capsules for Colon Delivery Combining Time-Controlled and Enzyme-Triggered Approaches. Int J Mol Sci 2020;21:E1917. [PMID: 32168895 DOI: 10.3390/ijms21061917] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Wathoni N, Nguyen AN, Rusdin A, Umar AK, Mohammed AFA, Motoyama K, Joni IM, Muchtaridi M. Enteric-Coated Strategies in Colorectal Cancer Nanoparticle Drug Delivery System. Drug Des Devel Ther 2020;14:4387-405. [PMID: 33116423 DOI: 10.2147/DDDT.S273612] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
79 Sriram A, Tangirala S, Atmakuri S, Hoque S, Modani S, Srivastava S, Mahajan S, Maji I, Kumar R, Khatri D, Madan J, Singh PK. Budding Multi-matrix Technology-a Retrospective Approach, Deep Insights, and Future Perspectives. AAPS PharmSciTech 2021;22:264. [PMID: 34734325 DOI: 10.1208/s12249-021-02133-4] [Reference Citation Analysis]
80 Berardi A, Bisharat L, Alkhatib HS, Cespi M. Zein as a Pharmaceutical Excipient in Oral Solid Dosage Forms: State of the Art and Future Perspectives. AAPS PharmSciTech 2018;19:2009-22. [DOI: 10.1208/s12249-018-1035-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
81 Hou Y, Jin J, Duan H, Liu C, Chen L, Huang W, Gao Z, Jin M. Targeted therapeutic effects of oral inulin-modified double-layered nanoparticles containing chemotherapeutics on orthotopic colon cancer. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121440] [Reference Citation Analysis]
82 Ghasemi S, Farsangi ZJ, Beitollahi A, Mirkazemi M, Rezayat S, Sarkar S. Synthesis of hollow mesoporous silica (HMS) nanoparticles as a candidate for sulfasalazine drug loading. Ceramics International 2017;43:11225-32. [DOI: 10.1016/j.ceramint.2017.05.172] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 3.6] [Reference Citation Analysis]
83 Manda JN, Markovic M, Zimmermann EM, Ben-Shabat S, Dahan A, Aponick A. Phospholipid Cyclosporine Prodrugs Targeted at Inflammatory Bowel Disease (IBD) Treatment: Design, Synthesis, and in Vitro Validation. ChemMedChem 2020;15:1639-44. [PMID: 32618133 DOI: 10.1002/cmdc.202000317] [Reference Citation Analysis]
84 Alshehri SM, Al-lohedan HA, Chaudhary AA, Al-farraj E, Alhokbany N, Issa Z, Alhousine S, Ahamad T. Delivery of ibuprofen by natural macroporous sporopollenin exine capsules extracted from Phoenix dactylifera L. European Journal of Pharmaceutical Sciences 2016;88:158-65. [DOI: 10.1016/j.ejps.2016.02.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
85 Ng YM, Mat Yusuf SNA, Chiu HI, Lim V. Redox-Sensitive Linear and Cross-Linked Cystamine-Based Polymers for Colon-Targeted Drug Delivery: Design, Synthesis, and Characterisation. Pharmaceutics 2020;12:E461. [PMID: 32443633 DOI: 10.3390/pharmaceutics12050461] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
86 Park S, Choi SK, Choi Y, Moon HS. AMPK/p53 Axis Is Essential for α-Lipoic Acid-Regulated Metastasis in Human and Mouse Colon Cancer Cells. J Investig Med 2015;63:882-5. [PMID: 26312825 DOI: 10.1097/JIM.0000000000000233] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
87 Lozoya-Agullo I, González-Álvarez I, Merino-Sanjuán M, Bermejo M, González-Álvarez M. Preclinical models for colonic absorption, application to controlled release formulation development. Eur J Pharm Biopharm 2018;130:247-59. [PMID: 30064699 DOI: 10.1016/j.ejpb.2018.07.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
88 Tiryaki E, Başaran Elalmış Y, Karakuzu İkizler B, Yücel S. Novel organic/inorganic hybrid nanoparticles as enzyme-triggered drug delivery systems: Dextran and Dextran aldehyde coated silica aerogels. Journal of Drug Delivery Science and Technology 2020;56:101517. [DOI: 10.1016/j.jddst.2020.101517] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 5.5] [Reference Citation Analysis]
89 El-hady SM, Aboughaly MH, El-ashmoony MM, Helmy HS, El-gazayerly ON. Colon targeting of celecoxib nanomixed micelles using pulsatile drug delivery systems for the prevention of inflammatory bowel disease. International Journal of Pharmaceutics 2020;576:118982. [DOI: 10.1016/j.ijpharm.2019.118982] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
90 Pandey S, Swamy SMV, Gupta A, Koli A, Patel S, Maulvi F, Vyas B. Multiple response optimisation of processing and formulation parameters of pH sensitive sustained release pellets of capecitabine for targeting colon. Journal of Microencapsulation 2018;35:259-71. [DOI: 10.1080/02652048.2018.1465138] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
91 Stillhart C, Vučićević K, Augustijns P, Basit AW, Batchelor H, Flanagan TR, Gesquiere I, Greupink R, Keszthelyi D, Koskinen M, Madla CM, Matthys C, Miljuš G, Mooij MG, Parrott N, Ungell A, de Wildt SN, Orlu M, Klein S, Müllertz A. Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review. European Journal of Pharmaceutical Sciences 2020;147:105280. [DOI: 10.1016/j.ejps.2020.105280] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 18.5] [Reference Citation Analysis]
92 Guo Y, Zong S, Pu Y, Xu B, Zhang T, Wang B. Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease. Molecules 2018;23:E1622. [PMID: 29973488 DOI: 10.3390/molecules23071622] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
93 Kahya N, Erim FB. Surfactant modified alginate composite gels for controlled release of protein drug. Carbohydr Polym 2019;224:115165. [PMID: 31472829 DOI: 10.1016/j.carbpol.2019.115165] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
94 Derakhshande P, Navabi SJ, Shokoohinia Y, Rouhi-Broujeni H, Deris F, Behbood L, Shahbazi F, Amiri M, Farzaei MH. Efficacy and safety of Achillea wilhelmsii C. Koch capsules on symptom severity and quality of life in patients with irritable bowel syndrome: a randomized, placebo-controlled clinical trial. J Complement Integr Med 2019;16:/j/jcim. [PMID: 31442203 DOI: 10.1515/jcim-2018-0123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
95 Kapote DN, Wagner KG. Shellac- a natural carrier for colon targeting of indomethacin using hot melt extrusion. Drug Dev Ind Pharm 2021;47:748-57. [PMID: 34038307 DOI: 10.1080/03639045.2021.1934863] [Reference Citation Analysis]
96 Pinto LA, Corá LA, Rodrigues GS, Prospero AG, Soares GA, de Andreis U, de Arruda Miranda JR. Pharmacomagnetography to evaluate the performance of magnetic enteric-coated tablets in the human gastrointestinal tract. Eur J Pharm Biopharm 2021;161:50-5. [PMID: 33592280 DOI: 10.1016/j.ejpb.2021.02.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
97 Tang H, Fang Z, Ng K. Dietary fiber-based colon-targeted delivery systems for polyphenols. Trends in Food Science & Technology 2020;100:333-48. [DOI: 10.1016/j.tifs.2020.04.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
98 Bak A, Ashford M, Brayden D. Local delivery of macromolecules to treat diseases associated with the colon. Advanced Drug Delivery Reviews 2018;136-137:2-27. [DOI: 10.1016/j.addr.2018.10.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
99 Čalija B, Milić J. Targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: Conventional and novel approaches. Arhiv za farmaciju 2017;67:124-42. [DOI: 10.5937/arhfarm1702124c] [Reference Citation Analysis]
100 Dahan A, Markovic M, Epstein S, Cohen N, Zimmermann EM, Aponick A, Ben-shabat S. Phospholipid-drug conjugates as a novel oral drug targeting approach for the treatment of inflammatory bowel disease. European Journal of Pharmaceutical Sciences 2017;108:78-85. [DOI: 10.1016/j.ejps.2017.06.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
101 Caspi M, Wittenstein A, Kazelnik M, Shor-Nareznoy Y, Rosin-Arbesfeld R. Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders. Adv Drug Deliv Rev 2021;169:118-36. [PMID: 33346022 DOI: 10.1016/j.addr.2020.12.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
102 Kaur M, Santhiya D. Fabrication of soy film with in-situ mineralized bioactive glass as a functional food for bone health. Food Bioscience 2022. [DOI: 10.1016/j.fbio.2022.101767] [Reference Citation Analysis]
103 de Oliveira FM, Bunhak ÉJ, Dos Santos LF, Barros PD, Cavalcanti OA. α-Gluco-oligosaccharide in the research and development of a polymeric material for modified drug delivery. Heliyon 2019;5:e03053. [PMID: 31890971 DOI: 10.1016/j.heliyon.2019.e03053] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
104 Dubey SK, Parab S, Dabholkar N, Agrawal M, Singhvi G, Alexander A, Bapat RA, Kesharwani P. Oral peptide delivery: challenges and the way ahead. Drug Discov Today 2021;26:931-50. [PMID: 33444788 DOI: 10.1016/j.drudis.2021.01.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
105 Moustafine RI, Sitenkov AY, Bukhovets AV, Nasibullin SF, Appeltans B, Kabanova TV, Khutoryanskiy VV, Van den Mooter G. Indomethacin-containing interpolyelectrolyte complexes based on Eudragit ® E PO/S 100 copolymers as a novel drug delivery system. International Journal of Pharmaceutics 2017;524:121-33. [DOI: 10.1016/j.ijpharm.2017.03.053] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
106 Hosseini S, Wey K, Epple M. Enteric Coating Systems for the Oral Administration of Bioactive Calcium Phosphate Nanoparticles Carrying Nucleic Acids into the Colon. ChemistrySelect 2020;5:9720-9. [DOI: 10.1002/slct.202002846] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Naeem M, Awan UA, Subhan F, Cao J, Hlaing SP, Lee J, Im E, Jung Y, Yoo J. Advances in colon-targeted nano-drug delivery systems: challenges and solutions. Arch Pharm Res 2020;43:153-69. [DOI: 10.1007/s12272-020-01219-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 13.5] [Reference Citation Analysis]
108 Aguirre TAS, Aversa V, Rosa M, Guterres SS, Pohlmann AR, Coulter I, Brayden DJ. Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage. J Control Release 2016;238:242-52. [PMID: 27480451 DOI: 10.1016/j.jconrel.2016.07.047] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
109 Kaur J, Gulati M, Gowthamarajan K, Vishwas S, Kumar Chellappan D, Gupta G, Dua K, Pandey NK, Kumar B, Singh SK. Combination therapy of vanillic acid and oxaliplatin co-loaded in polysaccharide based functionalized polymeric micelles could offer effective treatment for colon cancer: A hypothesis. Med Hypotheses 2021;156:110679. [PMID: 34555619 DOI: 10.1016/j.mehy.2021.110679] [Reference Citation Analysis]
110 Phanchana M, Harnvoravongchai P, Wongkuna S, Phetruen T, Phothichaisri W, Panturat S, Pipatthana M, Charoensutthivarakul S, Chankhamhaengdecha S, Janvilisri T. Frontiers in antibiotic alternatives for Clostridioides difficile infection. World J Gastroenterol 2021; 27(42): 7210-7232 [PMID: 34876784 DOI: 10.3748/wjg.v27.i42.7210] [Reference Citation Analysis]
111 Dos Santos AM, Carvalho SG, Meneguin AB, Sábio RM, Gremião MPD, Chorilli M. Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives. J Control Release 2021;334:353-66. [PMID: 33901582 DOI: 10.1016/j.jconrel.2021.04.026] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
112 Martínez-lópez A, Carvajal-millan E, Sotelo-cruz N, Micard V, Rascón-chu A, López-franco Y, Lizardi-mendoza J, Canett-romero R. Enzymatically cross-linked arabinoxylan microspheres as oral insulin delivery system. International Journal of Biological Macromolecules 2019;126:952-9. [DOI: 10.1016/j.ijbiomac.2018.12.192] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 6.7] [Reference Citation Analysis]
113 Human C, De Beer D, Bowles S, Joubert E. Effect of electrospraying conditions on the properties of aspalathin‐Eudragit S100 nanoparticles and assessment of orogastrointestinal stability and membrane permeability. Food Frontiers. [DOI: 10.1002/fft2.131] [Reference Citation Analysis]
114 Priyam A, Shivhare K, Yadav S, Sharma AK, Kumar P. Enhanced solubility and self-assembly of amphiphilic sulfasalazine-PEG-OMe (S-PEG) conjugate into core-shell nanostructures useful for colonic drug delivery. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2018;547:157-67. [DOI: 10.1016/j.colsurfa.2018.03.048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
115 Musa N, Wong TW. Design of polysaccharidic nano-in-micro soft agglomerates as primary oral drug delivery vehicle for colon-specific targeting. Carbohydrate Polymers 2020;247:116673. [DOI: 10.1016/j.carbpol.2020.116673] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
116 Alvarez-Lorenzo C, Garcia-Gonzalez CA, Bucio E, Concheiro A. Stimuli-responsive polymers for antimicrobial therapy: drug targeting, contact-killing surfaces and competitive release. Expert Opin Drug Deliv 2016;13:1109-19. [PMID: 27074830 DOI: 10.1080/17425247.2016.1178719] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
117 Sharma S, Sinha VR. Current pharmaceutical strategies for efficient site specific delivery in inflamed distal intestinal mucosa. Journal of Controlled Release 2018;272:97-106. [DOI: 10.1016/j.jconrel.2018.01.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
118 Deshmukh R, Harwansh RK, Paul SD, Shukla R. Controlled release of sulfasalazine loaded amidated pectin microparticles through Eudragit S 100 coated capsule for management of inflammatory bowel disease. Journal of Drug Delivery Science and Technology 2020;55:101495. [DOI: 10.1016/j.jddst.2019.101495] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
119 Gadziński P, Osmałek TZ, Froelich A, Wilmańska O, Nowak A, Tatarek A. Rheological and textural analysis as tools for investigation of drug-polymer and polymer-polymer interactions on the example of low-acyl gellan gum and mesalazine. J Biomater Appl 2022;:8853282211052755. [PMID: 34994229 DOI: 10.1177/08853282211052755] [Reference Citation Analysis]
120 Ma Y, Thurecht KJ, Coombes AGA. Development of enteric-coated, biphasic chitosan/HPMC microcapsules for colon-targeted delivery of anticancer drug-loaded nanoparticles. Int J Pharm 2021;607:121026. [PMID: 34418474 DOI: 10.1016/j.ijpharm.2021.121026] [Reference Citation Analysis]
121 Abid M, Naveed M, Azeem I, Faisal A, Faizan Nazar M, Yameen B. Colon specific enzyme responsive oligoester crosslinked dextran nanoparticles for controlled release of 5-fluorouracil. International Journal of Pharmaceutics 2020;586:119605. [DOI: 10.1016/j.ijpharm.2020.119605] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
122 Huizing LRS, Mcduffie J, Cuyckens F, van Heerden M, Koudriakova T, Heeren RMA, Vreeken RJ. Quantitative Mass Spectrometry Imaging to Study Drug Distribution in the Intestine Following Oral Dosing. Anal Chem 2021;93:2144-51. [DOI: 10.1021/acs.analchem.0c03956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
123 Tang L, Lin F, Li T, Cai Z, Hong B, Huang B. Design and synthesis of functionalized cellulose nanocrystals-based drug conjugates for colon-targeted drug delivery. Cellulose 2018;25:4525-36. [DOI: 10.1007/s10570-018-1904-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
124 Rajpoot K, Jain SK. Oral delivery of pH-responsive alginate microbeads incorporating folic acid-grafted solid lipid nanoparticles exhibits enhanced targeting effect against colorectal cancer: A dual-targeted approach. International Journal of Biological Macromolecules 2020;151:830-44. [DOI: 10.1016/j.ijbiomac.2020.02.132] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
125 Güner OZ, Cam C, Arabacioglu-kocaaga B, Batirel S, Güner FS. Theophylline-loaded pectin-based hydrogels. I. Effect of medium pH and preparation conditions on drug release profile. J Appl Polym Sci 2018;135:46731. [DOI: 10.1002/app.46731] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
126 Eder P, Zielińska A, Karczewski J, Dobrowolska A, Słomski R, Souto EB. How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions. J Nanobiotechnology 2021;19:346. [PMID: 34715852 DOI: 10.1186/s12951-021-01090-1] [Reference Citation Analysis]
127 Ghobashy MM, Elbarbary AM, Hegazy DE. Gamma radiation synthesis of a novel amphiphilic terpolymer hydrogel pH-responsive based chitosan for colon cancer drug delivery. Carbohydr Polym 2021;263:117975. [PMID: 33858572 DOI: 10.1016/j.carbpol.2021.117975] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
128 Ferri D, Gaviña P, Parra M, Costero AM, El Haskouri J, Amorós P, Merino V, Teruel AH, Sancenón F, Martínez-Máñez R. Mesoporous silica microparticles gated with a bulky azo derivative for the controlled release of dyes/drugs in colon. R Soc Open Sci 2018;5:180873. [PMID: 30225077 DOI: 10.1098/rsos.180873] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
129 Swain SS, Paidesetty SK, Padhy RN. Antibacterial activity, computational analysis and host toxicity study of thymol-sulfonamide conjugates. Biomedicine & Pharmacotherapy 2017;88:181-93. [DOI: 10.1016/j.biopha.2017.01.036] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
130 Abdullah S, El Hadad S, Aldahlawi A. In vitro optimization, characterization and anti-tumor evaluation against colorectal cancer of a novel 5-fluorouracil oral nanosuspension using soy protein, polysaccharides-protein complexation, and in-situ gel formation. Journal of Drug Delivery Science and Technology 2022;67:102857. [DOI: 10.1016/j.jddst.2021.102857] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
131 Deng XQ, Zhang HB, Wang GF, Xu D, Zhang WY, Wang QS, Cui YL. Colon-specific microspheres loaded with puerarin reduce tumorigenesis and metastasis in colitis-associated colorectal cancer. Int J Pharm 2019;570:118644. [PMID: 31465837 DOI: 10.1016/j.ijpharm.2019.118644] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
132 Malik DJ, Sokolov IJ, Vinner GK, Mancuso F, Cinquerrui S, Vladisavljevic GT, Clokie MRJ, Garton NJ, Stapley AGF, Kirpichnikova A. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Adv Colloid Interface Sci 2017;249:100-33. [PMID: 28688779 DOI: 10.1016/j.cis.2017.05.014] [Cited by in Crossref: 158] [Cited by in F6Publishing: 135] [Article Influence: 31.6] [Reference Citation Analysis]
133 Turanlı Y, Acartürk F. Preparation and characterization of colon-targeted pH/Time-dependent nanoparticles using anionic and cationic polymethacrylate polymers. Eur J Pharm Sci 2022;171:106122. [PMID: 35007712 DOI: 10.1016/j.ejps.2022.106122] [Reference Citation Analysis]
134 Zhao QQ, Zhang XY, Tang XF, Qiao H. A novel and oral colon targeted isoliquiritigenin delivery system: Development, optimization, characterization and in vitro evaluation. Journal of Drug Delivery Science and Technology 2021;66:102777. [DOI: 10.1016/j.jddst.2021.102777] [Reference Citation Analysis]
135 Wu Y, Li S, Jin M, Li D, Zhou Z, Hou H, Han Y. Preparation of MSZ Hydrogel and Its Treatment of Colitis. Front Pharmacol 2021;12:706401. [PMID: 34690753 DOI: 10.3389/fphar.2021.706401] [Reference Citation Analysis]
136 Wang S, Meng Y, Li J, Liu J, Liu Z, Li D. A novel and simple oral colon-specific drug delivery system based on the pectin/modified nano-carbon sphere nanocomposite gel films. International Journal of Biological Macromolecules 2020;157:170-6. [DOI: 10.1016/j.ijbiomac.2020.04.197] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
137 Wang Z, Zhou L, Xiong Y, Yu S, Li H, Fan J, Li F, Su Z, Song J, Sun Q, Liu SS, Xia Y, Zhao L, Li S, Guo F, Huang P, Carson DA, Lu D. Salinomycin exerts anti-colorectal cancer activity by targeting the β-catenin/T-cell factor complex. Br J Pharmacol 2019;176:3390-406. [PMID: 31236922 DOI: 10.1111/bph.14770] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
138 Moghimipour E, Rezaei M, Kouchak M, Fatahiasl J, Angali KA, Ramezani Z, Amini M, Dorkoosh FA, Handali S. Effects of coating layer and release medium on release profile from coated capsules with Eudragit FS 30D: an in vitro and in vivo study. Drug Dev Ind Pharm 2018;44:861-7. [PMID: 29235889 DOI: 10.1080/03639045.2017.1415927] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
139 Roth R, Schoelkopf J, Huwyler J, Puchkov M. Functionalized calcium carbonate microparticles for the delivery of proteins. Eur J Pharm Biopharm 2018;122:96-103. [PMID: 29054385 DOI: 10.1016/j.ejpb.2017.10.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
140 Pápay ZE, Kállai-Szabó N, Ludányi K, Klebovich I, Antal I. Development of oral site-specific pellets containing flavonoid extract with antioxidant activity. Eur J Pharm Sci 2016;95:161-9. [PMID: 27989856 DOI: 10.1016/j.ejps.2016.10.029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
141 Singh A, Kaur K, Mandal UK, Narang RK. Nanoparticles as Budding Trends in Colon Drug Delivery for the Management of Ulcerative Colitis. CNANOM 2020;10:225-47. [DOI: 10.2174/2468187310999200621200615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
142 Fowler S, Chen WLK, Duignan DB, Gupta A, Hariparsad N, Kenny JR, Lai WG, Liras J, Phillips JA, Gan J. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization. Lab Chip 2020;20:446-67. [PMID: 31932816 DOI: 10.1039/c9lc00857h] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 12.5] [Reference Citation Analysis]
143 Wang Z, Peng H, Guan Y, Yao S. Supercritical CO2 assisted micronization of curcumin-loaded oil-in-water emulsion promising in colon targeted delivery. Journal of CO2 Utilization 2022;59:101966. [DOI: 10.1016/j.jcou.2022.101966] [Reference Citation Analysis]
144 Stamatopoulos K, Karandikar S, Goldstein M, O'Farrell C, Marciani L, Sulaiman S, Hoad CL, Simmons MJH, Batchelor HK. Dynamic Colon Model (DCM): A Cine-MRI Informed Biorelevant In Vitro Model of the Human Proximal Large Intestine Characterized by Positron Imaging Techniques. Pharmaceutics 2020;12:E659. [PMID: 32668624 DOI: 10.3390/pharmaceutics12070659] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
145 Phanchana M, Phetruen T, Harnvoravongchai P, Raksat P, Ounjai P, Chankhamhaengdecha S, Janvilisri T. Repurposing a platelet aggregation inhibitor ticagrelor as an antimicrobial against Clostridioides difficile. Sci Rep 2020;10:6497. [PMID: 32300130 DOI: 10.1038/s41598-020-63199-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
146 Kang JH, Choi S, Jang JE, Ramalingam P, Ko YT, Kim SY, Oh SH. Wasabia japonica is a potential functional food to prevent colitis via inhibiting the NF-κB signaling pathway. Food Funct 2017;8:2865-74. [PMID: 28726958 DOI: 10.1039/c7fo00576h] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
147 Kotla NG, Rana S, Sivaraman G, Sunnapu O, Vemula PK, Pandit A, Rochev Y. Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives. Adv Drug Deliv Rev 2019;146:248-66. [PMID: 29966684 DOI: 10.1016/j.addr.2018.06.021] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 12.3] [Reference Citation Analysis]
148 Asgharzadeh F, Yaghoubi A, Nazari SE, Hashemzadeh A, Hasanian SM, Avan A, Javandoost A, Ferns GA, Soleimanpour S, Khazaei M. The beneficial effect of combination therapy with sulfasalazine and valsartan in the treatment of ulcerative colitis. EXCLI J 2021;20:236-47. [PMID: 33628160 DOI: 10.17179/excli2021-3370] [Reference Citation Analysis]
149 Dianzani C, Foglietta F, Ferrara B, Rosa AC, Muntoni E, Gasco P, Della Pepa C, Canaparo R, Serpe L. Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model. World J Gastroenterol 2017; 23(23): 4200-4210 [PMID: 28694660 DOI: 10.3748/wjg.v23.i23.4200] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
150 Cartaxo da Costa Urtiga S, Rodrigues Marcelino H, Sócrates Tabosa do Egito E, Eleamen Oliveira E. Xylan in drug delivery: A review of its engineered structures and biomedical applications. European Journal of Pharmaceutics and Biopharmaceutics 2020;151:199-208. [DOI: 10.1016/j.ejpb.2020.04.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Milivojevic M, Pajic-lijakovic I, Bugarski B, Nayak AK, Hasnain MS. Gellan gum in drug delivery applications. Natural Polysaccharides in Drug Delivery and Biomedical Applications. Elsevier; 2019. pp. 145-86. [DOI: 10.1016/b978-0-12-817055-7.00006-6] [Cited by in Crossref: 12] [Article Influence: 4.0] [Reference Citation Analysis]
152 Mohan LJ, Daly JS, Ryan BM, Ramtoola Z. The future of nanomedicine in optimising the treatment of inflammatory bowel disease. Scand J Gastroenterol 2019;54:18-26. [PMID: 30678499 DOI: 10.1080/00365521.2018.1563805] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
153 Viswanathan P, Muralidaran Y, Ragavan G. Challenges in oral drug delivery: a nano-based strategy to overcome. Nanostructures for Oral Medicine. Elsevier; 2017. pp. 173-201. [DOI: 10.1016/b978-0-323-47720-8.00008-0] [Cited by in Crossref: 24] [Article Influence: 4.8] [Reference Citation Analysis]
154 Goelen J, Alexander B, Wijesinghe HE, Evans E, Pawar G, Horniblow RD, Batchelor HK. Quantification of Fluid Volume and Distribution in the Paediatric Colon via Magnetic Resonance Imaging. Pharmaceutics 2021;13:1729. [PMID: 34684022 DOI: 10.3390/pharmaceutics13101729] [Reference Citation Analysis]
155 Alsaggar M, Liu D. Organ-based drug delivery. J Drug Target 2018;26:385-97. [PMID: 29419330 DOI: 10.1080/1061186X.2018.1437919] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
156 Coban O, Aytac Z, Yildiz ZI, Uyar T. Colon targeted delivery of niclosamide from β-cyclodextrin inclusion complex incorporated electrospun Eudragit® L100 nanofibers. Colloids Surf B Biointerfaces 2021;197:111391. [PMID: 33129100 DOI: 10.1016/j.colsurfb.2020.111391] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
157 Pomin SP, de Lima IA, Pezarini RR, Cavalcanti OA. Evaluation of Rosin Gum and Eudragit® RS PO as a Functional Film Coating Material. AAPS PharmSciTech 2017;18:2854-61. [PMID: 28411332 DOI: 10.1208/s12249-017-0766-5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
158 Koev TT, Harris HC, Kiamehr S, Khimyak YZ, Warren FJ. Starch hydrogels as targeted colonic drug delivery vehicles. Carbohydrate Polymers 2022;289:119413. [DOI: 10.1016/j.carbpol.2022.119413] [Reference Citation Analysis]
159 Bayan MF, Bayan RF. Recent advances in mesalamine colonic delivery systems. Futur J Pharm Sci 2020;6. [DOI: 10.1186/s43094-020-00057-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
160 Handali S, Moghimipour E, Rezaei M, Kouchak M, Ramezani Z, Dorkoosh FA. In vitro and in vivo evaluation of coated capsules for colonic delivery. Journal of Drug Delivery Science and Technology 2018;47:492-8. [DOI: 10.1016/j.jddst.2018.07.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
161 Pushpamalar J, Sathasivam T, Gugler MC. Hydrogel Beads of Natural Polymers as a Potential Vehicle for Colon-Targeted Drug Delivery. Methods Mol Biol 2021;2211:171-82. [PMID: 33336277 DOI: 10.1007/978-1-0716-0943-9_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
162 Chew SS, Tan LT, Law JW, Pusparajah P, Goh BH, Ab Mutalib NS, Lee LH. Targeting Gut Microbial Biofilms-A Key to Hinder Colon Carcinogenesis? Cancers (Basel) 2020;12:E2272. [PMID: 32823729 DOI: 10.3390/cancers12082272] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
163 Shokrollahi M, Chen J, Huizinga JD. Intraluminal prucalopride increases propulsive motor activities via luminal 5‐HT 4 receptors in the rabbit colon. Neurogastroenterology & Motility 2019;31. [DOI: 10.1111/nmo.13598] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
164 Tran PHL, Duan W, Lee BJ, Tran TTD. Drug stabilization in the gastrointestinal tract and potential applications in the colonic delivery of oral zein-based formulations. Int J Pharm 2019;569:118614. [PMID: 31415877 DOI: 10.1016/j.ijpharm.2019.118614] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
165 Maderuelo C, Lanao JM, Zarzuelo A. Enteric coating of oral solid dosage forms as a tool to improve drug bioavailability. European Journal of Pharmaceutical Sciences 2019;138:105019. [DOI: 10.1016/j.ejps.2019.105019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
166 Liparoti S, Franco P, Pantani R, De Marco I. Polycaprolactone/polyethylene-glycol capsules made by injection molding: A drug release modeling. Mater Sci Eng C Mater Biol Appl 2021;123:112036. [PMID: 33812648 DOI: 10.1016/j.msec.2021.112036] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]